Gates Foundation, UK government back CARB-X, boost antibiotics funding past $500M
→ The Bill and Melinda Gates Foundation has joined with the UK government to back CARB-X, a public private partnership that aims to support small biotechs developing new vaccines and antibiotics for the growing number of cases of drug resistance. The Gates Foundation is adding $25 million with the British government adding up to $27 million more. CARB-X now has more than $500 million to work with.
→ Sanofi’s new subsidiary Bioverativ has posted some new data demonstrating that its factor VIII therapy for hemophilia A — BIVV001 — extended the half-life of factor VIII to 37 hours.